While this morning was a bit of a rough start for biotech stocks, it seems as though things are changing rather quickly from red to green. In the space, there are several stocks gaining, but I’ve dug out what are some of the biggest gainers so far today. Here’s the scoop…
CIGNA Corporation Climbs On Acquisition Rumor
CIGNA Corporation (NYSE: CI)
CIGNA Corporation is having a great day in the market as rumors of a takeover by Anthem Inc continue to spread. Earlier today, Dow Jones stated that ANTM has initiated a takeover bid for CI; offering $175 per share. At that rate, ANTM is offering CI a 17% premium. Whether or not the takeover is actually going to happen is up in the air at the moment, but investors seem to be excited about the rumor. Currently (1:07), CI is trading at $156.17 per share after a gain of 13.74% so far today! Keep a close eye on this one as the rumors are likely to prove to be true!
Anthera Pharmaceuticals Stock Is Up On High Volume
Anthera Pharmaceuticals Inc (NASDAQ: ANTH)
Anthera Pharmaceuticals stock is also having a great day in the market; trading on incredibly high volume. Throughout the past 50 days, the average amount of shares that has traded hands on any given day has been 602,708. However, today is much different. So far (1:12) 1,702,992 shares have traded hands; which means we’ll most likely see quadruple the average volume on ANTH by the end of the day. The strong volume insinuates strong investor sentiment; so, I’m expecting this stock to go up for a good run. Keep an eye out for pull backs as they may turn into great opportunities. Currently, ANTH is trading at $8.94 per share after a gain of 15.51% so far today.
ZIOPHARM Oncology Stock Is Climbing After Reaching Support
ZIOPHARM Oncology Inc. (NASDAQ: ZIOP)
ZIOPHARM Oncology stock ended last week on a relatively bad note. However, the story is quite different today. After reaching support at $9.40 per share, we’ve seen a strong bullish run from the stock today. Currently (1:17), ZIOP is trading at $10.33 per share after a gain of 9.92% so far today. However, I don’t think these gains are over quite yet as the stock is likely to climb to resistance at $10.53 before a reversal. So, there’s still time to get in on the gains!
Opexa Therapeutics Stock Is Looking For A Breakout
Opexa Therapeutics Inc (NASDAQ: OPXA)
Opexa Therapeutics stock is becoming a very fun one to watch. For the past month, we’ve seen resistance between $0.60 and $0.61. However, for the past week, we’ve watched as the stock has traded very close to the resistance line with few dips that don’t go too far down; bringing support up. As support and resistance get close together, chances of a strong breakout are higher; and based on the fact that support is climbing, I’m expecting the breakout to be in the bullish direction. So, watch this one closely. If the price breaks the $0.61 per share mark, we can expect to see strong bullish activity from OPXA!
Do You Know Of Any Others?
Are you tracking any other strong gainers in biotech? If so, let us know what they are in the comments below!